UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial

PloS one, 2017-07, Vol.12 (7), p.e0180762-e0180762

2017

Volltextzugriff (PDF)

A potent Lassa virus antiviral targets an arenavirus virulence determinant

PLoS pathogens, 2018-12, Vol.14 (12), p.e1007439-e1007439

2018

Volltextzugriff (PDF)

Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis

Rheumatology (Oxford, England), 2024-01, Vol.63 (1), p.198-208

2024

Volltextzugriff (PDF)

Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway

Journal of virology, 2016-03, Vol.90 (5), p.2372-2387

2016

Volltextzugriff (PDF)

1357 CD27 is a new promising T cell co-stimulatory target for the cancer immunotherapy – development and selection of a lead anti-CD27 agonist antibody

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1511-A1511

2023

Volltextzugriff (PDF)

Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases

Toxicon (Oxford), 2012-03, Vol.59 (4), p.529-546

2012

Volltextzugriff (PDF)

A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Frontiers in immunology, 2023-12, Vol.14, p.1311658

2023

Volltextzugriff (PDF)

Extracellular 2′-5′ Oligoadenylate Synthetase Stimulates RNase L-Independent Antiviral Activity: a Novel Mechanism of Virus-Induced Innate Immunity

Journal of Virology, 2010-11, Vol.84 (22), p.11898-11904

2010

Volltextzugriff (PDF)

780 VISTA-101 – A phase 1/2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, alone and in combination with pembrolizumab in advanced solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A877-A877

2023

Volltextzugriff (PDF)

Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases

The FASEB journal, 2014-09, Vol.28 (9), p.3952-3964

2014

Volltextzugriff (PDF)

A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response

Vaccine, 2017-04, Vol.35 (15), p.1964-1971

2017

Volltextzugriff (PDF)

Isoflavone Agonists of IRF-3 Dependent Signaling Have Antiviral Activity against RNA Viruses

Journal of Virology, 2012-07, Vol.86 (13), p.7334-7344

2012

Volltextzugriff (PDF)

Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Frontiers in immunology, 2024, Vol.15, p.1365240-1365240

2024

Volltextzugriff (PDF)

Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease

The Journal of pharmacology and experimental therapeutics, 2012-09, Vol.342 (3), p.642-653

2012

Volltextzugriff (PDF)

Association of the FTO Gene With BMI

Obesity (Silver Spring, Md.), 2008-04, Vol.16 (4), p.902-904

2008

Volltextzugriff (PDF)

Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis

Frontiers in immunology, 2017-09, Vol.8, p.1205-1205

2017

Volltextzugriff (PDF)

Genomics Hepatitis C virus gets personal

Nature (London), 2009-09, Vol.461 (7262), p.357-358

2009

Volltextzugriff (PDF)

879 A promising cancer immunotherapy target: novel fully human agonist antibodies against the human T-cell costimulatory receptor CD27

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A921-A921

2021

Volltextzugriff (PDF)

VISTA a Potential New Immuno-Oncology Target in Acute Myeloid Leukemia

Blood, 2023-11, Vol.142 (Supplement 1), p.5965-5965

2023

Volltextzugriff (PDF)

Hepatitis C virus gets personal

Nature (London), 2009-09, Vol.461 (7262), p.357-358

2009

Volltextzugriff (PDF)

High-density rhesus macaque oligonucleotide microarray design using early-stage rhesus genome sequence information and human genome annotations

BMC genomics, 2007-01, Vol.8 (1), p.28-28, Article 28

2007

Volltextzugriff (PDF)

Abstract B034: CD27 is a new promising T cell co-stimulatory target for cancer immunotherapy

Cancer immunology research, 2023-12, Vol.11 (12_Supplement), p.B034-B034

2023

Volltextzugriff (PDF)

Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections

Vaccine, 2007-08, Vol.25 (35), p.6458-6473

2007

Volltextzugriff (PDF)

CS06-3. Identification of RLR-activating compounds as novel antiviral therapeutics or vaccine adjuvants

Cytokine (Philadelphia, Pa.), 2011-10, Vol.56 (1), p.14-14

2011

Volltextzugriff (PDF)

Abstract P21: VISTA a potential new Immuno-oncology therapeutic target to treat human Acute Myeloid Leukemia

Blood cancer discovery, 2024-03, Vol.5 (2_Supplement), p.P21-P21

2024

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieProceedings Of The National Academy Of Sciences - Pnas

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(56)
Dissertationen
(1)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Humans
(17)
Life Sciences & Biomedicine
(17)
Animals
(10)
Female
(6)
Immunotherapy
(6)
Immunology
(5)
Biological And Medical Sciences
(4)
Genetics & Heredity
(4)
Male
(4)
Mice
(4)
Molecular Sequence Data
(4)
Virology
(4)
Adult
(3)
Amino Acid Sequence
(3)
Biotechnology & Applied Microbiology
(3)
Care And Treatment
(3)
Cell Line
(3)
Cytokines
(3)
Cytokines - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial

A potent Lassa virus antiviral targets an arenavirus virulence determinant

Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis

Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway

1357 CD27 is a new promising T cell co-stimulatory target for the cancer immunotherapy – development and selection of a lead anti-CD27 agonist antibody

Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases

A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Extracellular 2′-5′ Oligoadenylate Synthetase Stimulates RNase L-Independent Antiviral Activity: a Novel Mechanism of Virus-Induced Innate Immunity

780 VISTA-101 – A phase 1/2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, alone and in combination with pembrolizumab in advanced solid tumors

Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases

A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response

Isoflavone Agonists of IRF-3 Dependent Signaling Have Antiviral Activity against RNA Viruses

Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease

Association of the FTO Gene With BMI

Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis

Genomics Hepatitis C virus gets personal

879 A promising cancer immunotherapy target: novel fully human agonist antibodies against the human T-cell costimulatory receptor CD27

VISTA a Potential New Immuno-Oncology Target in Acute Myeloid Leukemia

Hepatitis C virus gets personal

High-density rhesus macaque oligonucleotide microarray design using early-stage rhesus genome sequence information and human genome annotations

Abstract B034: CD27 is a new promising T cell co-stimulatory target for cancer immunotherapy

Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections

CS06-3. Identification of RLR-activating compounds as novel antiviral therapeutics or vaccine adjuvants

Abstract P21: VISTA a potential new Immuno-oncology therapeutic target to treat human Acute Myeloid Leukemia

Aktive Filter

Suchergebnisse filtern